Effects of excipients on hydrate formation in wet masses containing theophylline
Research output: Contribution to journal › Journal article › peer-review
Standard
Effects of excipients on hydrate formation in wet masses containing theophylline. / Airaksinen, Sari; Luukkonen, Pirjo; Jørgensen, Anna; Karjalainen, Milja; Rantanen, Jukka; Yliruusi, Jouko.
In: Journal of Pharmaceutical Sciences, Vol. 92, No. 3, 03.2003, p. 516-28.Research output: Contribution to journal › Journal article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Effects of excipients on hydrate formation in wet masses containing theophylline
AU - Airaksinen, Sari
AU - Luukkonen, Pirjo
AU - Jørgensen, Anna
AU - Karjalainen, Milja
AU - Rantanen, Jukka
AU - Yliruusi, Jouko
N1 - Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association
PY - 2003/3
Y1 - 2003/3
N2 - Transformations between solid phases in dosage forms can lead to instability in drug release. Thus, it is important to understand mechanisms and kinetics of phase transformations and factors that may influence them. During wet granulation theophylline shows pseudopolymorphic changes that may alter its dissolution rate. The aim of this study was to investigate whether excipients, such as alpha-lactose monohydrate or the highly water absorbing silicified microcrystalline cellulose (SMCC) can influence the hydrate formation of theophylline. In particular, the aim was to study if SMCC offers protection against the formation of theophylline monohydrate relative to alpha-lactose monohydrate in wet masses after an overnight equilibration and the stability of final granules during controlled storage. In addition, the aim was to study the use of spectroscopic methods to identify hydrate formation in the formulations containing excipients. Off-line evaluation of materials was performed using X-ray powder diffractometry, near infrared and Raman spectroscopy. alpha-Lactose monohydrate with minimal water absorbing potential was not able to prevent but enhanced hydrate formation of theophylline. Even though SMCC is able to take large amounts of water into its internal structure, it was able to inhibit the formation of theophylline monohydrate only at low moisture contents, not at the amounts of water needed to form granules. Both the spectroscopic methods used could identify the hydrate formation even though there were excipients in the formulation.
AB - Transformations between solid phases in dosage forms can lead to instability in drug release. Thus, it is important to understand mechanisms and kinetics of phase transformations and factors that may influence them. During wet granulation theophylline shows pseudopolymorphic changes that may alter its dissolution rate. The aim of this study was to investigate whether excipients, such as alpha-lactose monohydrate or the highly water absorbing silicified microcrystalline cellulose (SMCC) can influence the hydrate formation of theophylline. In particular, the aim was to study if SMCC offers protection against the formation of theophylline monohydrate relative to alpha-lactose monohydrate in wet masses after an overnight equilibration and the stability of final granules during controlled storage. In addition, the aim was to study the use of spectroscopic methods to identify hydrate formation in the formulations containing excipients. Off-line evaluation of materials was performed using X-ray powder diffractometry, near infrared and Raman spectroscopy. alpha-Lactose monohydrate with minimal water absorbing potential was not able to prevent but enhanced hydrate formation of theophylline. Even though SMCC is able to take large amounts of water into its internal structure, it was able to inhibit the formation of theophylline monohydrate only at low moisture contents, not at the amounts of water needed to form granules. Both the spectroscopic methods used could identify the hydrate formation even though there were excipients in the formulation.
KW - Absorption
KW - Chemistry, Pharmaceutical
KW - Excipients
KW - Lactose
KW - Theophylline
KW - Water
KW - Wettability
U2 - 10.1002/jps.10328
DO - 10.1002/jps.10328
M3 - Journal article
C2 - 12587113
VL - 92
SP - 516
EP - 528
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
SN - 0022-3549
IS - 3
ER -
ID: 140622166